Metraipolis › archive › dc_5cd55438c31e

Exploring ceramide as a novel biomarker and therapeutic target for Alzheimer's disease — Europe PMC PMID:42325951

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42325951
DOI
10.3389/fnins.2026.1771302
License (as archived)
solo-consultazione
Archived
2026-10-31T18:20:23.368Z
SHA-256 of the archived text
4d8b02cabca3cae5f2d72aa73f89aa0be2b07b2a4d41de00bf67c0b7a976dfa7
Stable URL of this page
https://metraipolis.com/documento/dc_5cd55438c31e

How to cite

Exploring ceramide as a novel biomarker and therapeutic target for Alzheimer's disease — Europe PMC PMID:42325951 — Europe PMC (en), https://europepmc.org/article/MED/42325951 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5cd55438c31e (Metraipolis archive dc_5cd55438c31e, sha256 4d8b02cabca3cae5f2d72aa73f89aa0be2b07b2a4d41de00bf67c0b7a976dfa7)
BibTeX
@misc{dc5cd55438c31e,
  title = {Exploring ceramide as a novel biomarker and therapeutic target for Alzheimer's disease — Europe PMC PMID:42325951},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42325951},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5cd55438c31e; sha256 4d8b02cabca3cae5f2d72aa73f89aa0be2b07b2a4d41de00bf67c0b7a976dfa7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42325951. Agents can read the archived copy with the MCP tool read_document.